Plunkett Research Online: Xenetic Biosciences

XENETIC BIOSCIENCES (XBIO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod.....



Xenetic Biosciences
Ticker: XBIO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 778-7720
Fax:
Address: 99 Hayden Avenue
Suite 230
Lexington, MA 02421 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing
ContactsDescription
Jeffrey EisenbergCEO/Director
James ParslowCFO/Chief Accounting Officer
See More
Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod.....See More See More

Auditor: Marcum LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: